[HTML][HTML] Tissue engineering and regenerative medicine: achievements, future, and sustainability in Asia

F Han, J Wang, L Ding, Y Hu, W Li, Z Yuan… - … in bioengineering and …, 2020 - frontiersin.org
Exploring innovative solutions to improve the healthcare of the aging and diseased
population continues to be a global challenge. Among a number of strategies toward this …

Concise review: laying the groundwork for a first-in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury

O Tsuji, K Sugai, R Yamaguchi, S Tashiro… - Stem …, 2019 - academic.oup.com
There have been numerous attempts to develop stem cell transplantation approaches to
promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently …

[HTML][HTML] Cell therapy for spinal cord injury using induced pluripotent stem cells

N Nagoshi, O Tsuji, M Nakamura, H Okano - Regenerative therapy, 2019 - Elsevier
For the past few decades, spinal cord injury (SCI) has been believed to be an incurable
traumatic condition, but with recent developments in stem cell biology, the field of …

In vitro modeling of the bipolar disorder and schizophrenia using patient-derived induced pluripotent stem cells with copy number variations of PCDH15 and RELN

T Ishii, M Ishikawa, K Fujimori, T Maeda, I Kushima… - Eneuro, 2019 - eneuro.org
Bipolar disorder (BP) and schizophrenia (SCZ) are major psychiatric disorders, but the
molecular mechanisms underlying the complicated pathologies of these disorders remain …

[HTML][HTML] Oligodendrocytes in human induced pluripotent stem cell-derived cortical grafts remyelinate adult rat and human cortical neurons

R Martinez-Curiel, L Jansson, O Tsupykov, N Avaliani… - Stem Cell Reports, 2023 - cell.com
Neuronal loss and axonal demyelination underlie long-term functional impairments in
patients affected by brain disorders such as ischemic stroke. Stem cell-based approaches …

[HTML][HTML] Modeling Parkinson's disease using patient-specific induced pluripotent stem cells

H Li, H Jiang, B Zhang, J Feng - Journal of Parkinson's …, 2018 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the degeneration of nigral dopaminergic (DA) neurons. While over 90% of …

[HTML][HTML] Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells

T Sanosaka, H Okuno, N Mizota, T Andoh-Noda… - Scientific reports, 2022 - nature.com
A mutation in the chromatin remodeler chromodomain helicase DNA-binding 7 (CHD7)
gene causes the multiple congenital anomaly CHARGE syndrome. The craniofacial …

[HTML][HTML] Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases

K Sugai, R Fukuzawa, T Shofuda, H Fukusumi… - Molecular brain, 2016 - Springer
The risk of tumorigenicity is a hurdle for regenerative medicine using induced pluripotent
stem cells (iPSCs). Although teratoma formation is readily distinguishable, the malignant …

[HTML][HTML] Postsynaptic structure formation of human iPS cell-derived neurons takes longer than presynaptic formation during neural differentiation in vitro

K Togo, H Fukusumi, T Shofuda, H Ohnishi… - Molecular Brain, 2021 - Springer
The generation of mature synaptic structures using neurons differentiated from human-
induced pluripotent stem cells (hiPSC-neurons) is expected to be applied to physiological …

[HTML][HTML] Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation

M Isoda, T Sanosaka, R Tomooka, Y Mabuchi… - Communications …, 2023 - nature.com
Although neural stem/progenitor cells derived from human induced pluripotent stem cells
(hiPSC-NS/PCs) are expected to be a cell source for cell-based therapy, tumorigenesis of …